Denali Therapeutics, Inc. (DNLI)
24.20
-0.72
(-2.89%)
USD |
NASDAQ |
Aug 24, 16:00
23.73
-0.47
(-1.94%)
After-Hours: 20:00
Denali Therapeutics Profit Margin (Quarterly) : -3.54K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.54K% |
| March 31, 2026 | |
| December 31, 2025 | |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | -7.84K% |
| June 30, 2023 | 62.35% |
| March 31, 2023 | -312.4% |
| December 31, 2022 | -959.6% |
| September 30, 2022 | -2.90K% |
| June 30, 2022 | -112.0% |
| Date | Value |
|---|---|
| March 31, 2022 | -154.8% |
| December 31, 2021 | -601.4% |
| September 30, 2021 | -1.60K% |
| June 30, 2021 | -264.6% |
| March 31, 2021 | -884.0% |
| December 31, 2020 | 77.30% |
| September 30, 2020 | -619.9% |
| June 30, 2020 | -1.00K% |
| March 31, 2020 | -1.58K% |
| December 31, 2019 | -1.16K% |
| September 30, 2019 | -340.0% |
| June 30, 2019 | -1.39K% |
| March 31, 2019 | -927.3% |
| December 31, 2018 | 61.69% |
| September 30, 2018 | -2.96K% |
| June 30, 2018 | -3.32K% |
| March 31, 2018 | -3.69K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Biogen, Inc. | 3.72% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | -1.22% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.08% |
| Return on Assets | -44.16% |
| Return on Invested Capital | -51.77% |
| Gross Profit Margin (Quarterly) | -52.39% |
| Operating Margin (Quarterly) | -3.62K% |
| Return on Net Operating Assets | -360.5% |